MIREYA LOMELI: Open Payments
NPI 1114640729 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 25 payments from 10 companies in 2025. Trend: 2023 $683 · 2024 $2,200 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $276 |
| Lilly USA, LLC | 3 | $68 |
| Exact Sciences Corporation | 3 | $58 |
| ABBVIE INC. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| PFIZER INC. | 1 | $21 |
| ABIOMED | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: FARXIGA, AIRSUPRA, RINVOQ, MOUNJARO, Cologuard Collection Kit, CAPVAXIVE, JARDIANCE, GARDASIL 9.
Industry payments across TX — which companies pay providers there.
